PI3K Inhibition Impairs BRCA1/2 Expression and Sensitizes BRCA-Proficient Triple-Negative Breast Cancer to PARP InhibitionYasir H. Ibrahim, José Baselga, Olga Rodríguez et al.|Cancer Discovery|2012Cited by 622
RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancerCristina Cruz, Violeta Serra, Marta Castroviejo‐Bermejo et al.|Annals of Oncology|2018Cited by 424
A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutationMarta Castroviejo‐Bermejo, Violeta Serra, Cristina Cruz et al.|EMBO Molecular Medicine|2018Cited by 271
Insulin Receptor Substrate Adaptor Proteins Mediate Prognostic Gene Expression Profiles in Breast CancerMarc A. Becker, Douglas Yee, Yasir H. Ibrahim et al.|PLoS ONE|2016Cited by 15
An affinity tool for the isolation of endogenous active mTORC1 from various cellular sourcesYasir H. Ibrahim, Anders P. Mutvei|Journal of Biological Chemistry|2023Cited by 2